accountThe world's second biggest pharmaceutical company is to radically shift its attitude to providing cheap drugs to millions of people in the developing world. In a major change of strategy, the new head of GlaxoSmithKline, Andrew Witty, has told the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Drug giant GlaxoSmithKline pledges cheap medicine for world's poor
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account